NeuroMetrix (NURO)
(Delayed Data from NSDQ)
$3.89 USD
-0.02 (-0.38%)
Updated Aug 28, 2024 02:17 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
NeuroMetrix, Inc. [NURO]
Reports for Purchase
Showing records 1 - 20 ( 65 total )
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Quell Commercial Strategy and Pursuit of Strategic Options Push Platform Forward
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Reported financial results for their Q1/2019
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Quell Strategy Update May Meaningfully Facilitate Uptake; Reit Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Continue to Believe Both Long-term Prospects and Valuation are Compelling; Reit Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: NeuroMetrix, Inc.
Industry: Medical - Products
An Underappreciated Commercial Company for Chronic Pain Management; Initiating With Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Company: NeuroMetrix, Inc.
Industry: Medical - Products
3Q17 Financial Results Reported; Reiterate Buy and Lowering Price Target to $3
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Neutral - More momentum for Quell, DPNCheck
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Quell Device and Electrode Shipments Growth Continued in 2Q17; Reiterate Buy and Adjusting Price Target to $10
Provider: Rodman & Renshaw, Co.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Quell Device and Electrode Shipments Growth Continued in 2Q17; Reiterate Buy and Adjusting Price Target to $10
Provider: H.C. Wainwright & Co., Inc.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Two New U.S. Patents Issued; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
Two New U.S. Patents Issued; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
One-for-Eight Reverse Split Effected; Reiterate Buy and Adjusting Price Target to $16
Provider: Rodman & Renshaw, Co.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
One-for-Eight Reverse Split Effected; Reiterate Buy and Adjusting Price Target to $16
Provider: H.C. Wainwright & Co., Inc.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
International Patent Expansion Paves Way for Potential Ex-U.S. Commercialization; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
International Patent Expansion Paves Way for Potential Ex-U.S. Commercialization; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: NeuroMetrix, Inc.
Industry: Medical - Products
First Quarter Results-Quell Shipments Up 130% YOY
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S